Eydelman Mikhail Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
18
Insider Sells Sum
$6.1M

Insider Activity of Eydelman Mikhail

Biography of Eydelman Mikhail

No biography is available at this moment.

2025-03-05SaleVaxcyte, Inc.
PCVX
SVP, GEN COUNSEL & CORP SEC
5,000
0.0037%
$70.74$353,699-49.42%
2025-02-05SaleVaxcyte, Inc.
PCVX
SVP, GEN COUNSEL & CORP SEC
5,000
0.0042%
$90.07$450,369-58.17%
2025-01-06SaleVaxcyte, Inc.
PCVX
SVP, GEN COUNSEL & CORP SEC
5,000
0.004%
$85.58$427,923-56.64%
2024-12-05SaleVaxcyte, Inc.
PCVX
SVP, GEN COUNSEL & CORP SEC
5,000
0.0041%
$91.49$457,434-58.59%
2024-11-05SaleVaxcyte, Inc.
PCVX
SVP, GEN COUNSEL & CORP SEC
5,000
0.0041%
$106.36$531,803-65.34%
2024-10-07SaleVaxcyte, Inc.
PCVX
SVP, GEN COUNSEL & CORP SEC
5,000
0.004%
$109.27$546,353-65.62%
2024-10-01SaleVaxcyte, Inc.
PCVX
SVP, GEN COUNSEL & CORP SEC
5,500
0.0046%
$114.24$628,295-67.73%
2024-09-03SaleVaxcyte, Inc.
PCVX
SVP, GEN COUNSEL & CORP SEC
1,667
0.0015%
$112.11$186,880-32.31%
2024-08-01SaleVaxcyte, Inc.
PCVX
SVP, GEN COUNSEL & CORP SEC
1,667
0.0015%
$78.85$131,449+0.55%
2024-07-01SaleVaxcyte, Inc.
PCVX
SVP, GEN COUNSEL & CORP SEC
1,667
0.0016%
$76.37$127,304+5.63%
2024-06-03SaleVaxcyte, Inc.
PCVX
SVP, GEN COUNSEL & CORP SEC
1,667
0.0015%
$72.06$120,127+12.5%
2024-05-01SaleVaxcyte, Inc.
PCVX
SVP, GEN COUNSEL & CORP SEC
1,667
0.0015%
$61.74$102,921+27.56%
2024-04-01SaleVaxcyte, Inc.
PCVX
SVP, GEN COUNSEL & CORP SEC
1,667
0.0015%
$66.73$111,234+21.64%
2024-03-01SaleVaxcyte, Inc.
PCVX
SVP, GEN COUNSEL & CORP SEC
1,667
0.0016%
$73.73$122,907+13.47%
2024-02-01SaleVaxcyte, Inc.
PCVX
SVP, GEN COUNSEL & CORP SEC
1,667
0.0019%
$73.87$123,144+5.01%
2024-01-02SaleVaxcyte, Inc.
PCVX
SVP, Gen Counsel & Corp Sec
1,667
0.0018%
$63.93$106,579+21.77%
2023-12-07SaleVaxcyte, Inc.
PCVX
SVP, Gen Counsel & Corp Sec
10,000
0.0104%
$56.50$565,000+31.75%
2023-10-02SaleVaxcyte, Inc.
PCVX
SVP, Gen Counsel & Corp Sec
20,000
0.0219%
$50.40$1.01M+41.11%
Total: 18
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.